Thank you! We would like to thank our readers, authors, reviewers and editorial board for their support in making The Lancet an authoritative and independent voice in the field of general and internal medicine.
Share this page:
FaceBookLinkedIntwitter
 
  Top 10 most cited articles*
The below-listed articles contributed the most to this year's newly released Impact Factor.
Click on the titles to read each article in full.
 
1. Global, regional, and national causes of child mortality in 2008: a systematic analysis
(2010) The Lancet, 375 (9730), pp. 1969-1987.
Cited 324 times


2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
(2010) The Lancet, 376 (9742), pp. 687- 97.
Cited 318 times


3. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
(2010) The Lancet, 375 (9720), pp. 1100-1108.
Cited 290 times


4. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5
(2010) The Lancet, 375 (9726), pp. 1609-1623.
Cited 281 times


5. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
(2010) The Lancet, 375 (9731), pp. 2073-2081.
Cited 263 times
6. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials
(2010) The Lancet, 376 (9753), pp. 1670-1681.
Cited 262 times


7. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
(2010) The Lancet, 375 (9719), pp. 985-997.
Cited 255 times


8. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
(2010) The Lancet, 375 (9709), pp. 132-140.
Cited 233 times


9. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial
(2010) The Lancet, 376 (9737), pp. 235-244.
Cited 225 times


10. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
(2010) The Lancet, 375 (9726), pp. 1624-1633.
Cited 211 times
*(Source: Scopus, June 2012; 2010-2011) 

Our commitment

We are committed to publishing the highest quality research, review and opinion. We deliver on our commitment by:
  • Rigorously peer-reviewing and editing all research for scientific relevance
  • Fast-Tracking eligible articles to publication within 4 weeks of submission, and publishing them online first reducing the time from submission to dissemination even further
  • Ensuring appropriate research receives international media coverage and is published with interpretive commentary by key opinion leaders
  • Disseminating your work to the medical community via TheLancet.com and ScienceDirect®

 
Learn how to become an author

Visit our Information for Authors page to learn more about the types of manuscripts accepted, how to submit your paper, and requirements for submission. > Visit our Information for Authors Guide
   
A free way to save time

Sign up for eTable of Contents alerts to be delivered directly to your inbox each week. This service is free and helps you save time with immediate linking to any article of interest. > Sign up for eToC alerts
   
Access free audio and video content

Listen to our free podcasts for author interviews and expert discussions. All podcasts are available from TheLancet.com and from the iTunes Store. > Access our podcast library

View video reports from TheLancet TV and Global Health TV for updates on work being done by health organizations around the world and interviews on important global health issues. > Access our video library


Share this page:
FaceBookLinkedIntwitter